Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Norco 10/325 (hydrocodone-acetaminophen) Treatment Report
What is Norco 10/325?

Norco 10/325 is a brand name for a combination of hydrocodone 10 mg and acetaminophen 325 mg used to relieve moderate to moderately severe pain.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Pain 7 3
Other 1 0
Support another treatment 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
1 33%
None
2 67%

Most commonly reported side effects

Constipation
1 33%
  • Mild
  • Moderate
  • Severe

Dosages

  2 325mg-10mg as needed 2 x 325 mg-10 mg all the time (24/7) 325mg-10mg as needed 2 x 325 mg-10 mg daily 4 x 325 mg-10 mg daily 5 x 325 mg-10 mg daily 8 x 325 mg-10 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Norco 10/325 (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
1 100% Did not seem to work: 100%
Not indicated
1 100% Not indicated: 100%

See all 1 patient who’ve stopped taking Norco 10/325

Currently Taking Norco 10/325

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
2
2
4

Stopped Taking Norco 10/325

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0
1

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
1 33%
Usually
1 33%
Sometimes
1 33%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
3 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
2 67%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 23, 2009.